Skip to main content

Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.

Publication ,  Journal Article
Chan, C; Bartolucci, A; Brenner, D; Presant, C; Davila, E; Carpenter, J; Greco, FA; Clamon, G; Moore, J
Published in: Cancer Treat Rep
March 1986

Duke Scholars

Published In

Cancer Treat Rep

ISSN

0361-5960

Publication Date

March 1986

Volume

70

Issue

3

Start / End Page

427 / 428

Location

United States

Related Subject Headings

  • Soft Tissue Neoplasms
  • Sarcoma
  • Naphthacenes
  • Middle Aged
  • Male
  • Humans
  • Female
  • Drug Resistance
  • Drug Evaluation
  • Bone Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chan, C., Bartolucci, A., Brenner, D., Presant, C., Davila, E., Carpenter, J., … Moore, J. (1986). Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial. Cancer Treat Rep, 70(3), 427–428.
Chan, C., A. Bartolucci, D. Brenner, C. Presant, E. Davila, J. Carpenter, F. A. Greco, G. Clamon, and J. Moore. “Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.Cancer Treat Rep 70, no. 3 (March 1986): 427–28.
Chan C, Bartolucci A, Brenner D, Presant C, Davila E, Carpenter J, et al. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial. Cancer Treat Rep. 1986 Mar;70(3):427–8.
Chan C, Bartolucci A, Brenner D, Presant C, Davila E, Carpenter J, Greco FA, Clamon G, Moore J. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial. Cancer Treat Rep. 1986 Mar;70(3):427–428.

Published In

Cancer Treat Rep

ISSN

0361-5960

Publication Date

March 1986

Volume

70

Issue

3

Start / End Page

427 / 428

Location

United States

Related Subject Headings

  • Soft Tissue Neoplasms
  • Sarcoma
  • Naphthacenes
  • Middle Aged
  • Male
  • Humans
  • Female
  • Drug Resistance
  • Drug Evaluation
  • Bone Neoplasms